Ozone Therapy After Open Flap Debridement in Periodontitis
OFD-OZONE
The Effect of Adjunctive Ozone Therapy on Clinical Outcomes Following Open Flap Debridement in Patients With Stage III Periodontitis: A Randomized Split-Mouth Clinical Trial
1 other identifier
interventional
24
1 country
1
Brief Summary
Periodontitis is a chronic inflammatory disease characterized by the destruction of supporting periodontal tissues. Open flap debridement (OFD) is a commonly used surgical approach for the treatment of deep periodontal pockets when non-surgical therapy is insufficient. However, complete elimination of pathogenic microorganisms remains challenging. Ozone therapy has been proposed as an adjunctive treatment due to its antimicrobial, anti-inflammatory, and wound healing properties. This randomized split-mouth clinical trial aims to evaluate the clinical effectiveness of adjunctive ozone therapy in patients with Stage III periodontitis undergoing OFD. A total of 24 systemically healthy patients diagnosed with Stage III periodontitis were included in the study. In each patient, one side was randomly assigned to receive OFD combined with ozone therapy (test group), while the contralateral side received OFD alone (control group). Clinical periodontal parameters, including plaque index (PI), gingival index (GI), bleeding on probing (BOP), probing pocket depth (PPD), and clinical attachment level (CAL), were recorded at baseline and at 6 and 12 months after treatment. The study aims to determine whether adjunctive ozone therapy improves clinical outcomes compared to conventional OFD alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 25, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 18, 2026
CompletedFirst Submitted
Initial submission to the registry
April 18, 2026
CompletedFirst Posted
Study publicly available on registry
April 24, 2026
CompletedApril 24, 2026
April 1, 2026
1.1 years
April 18, 2026
April 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Probing Pocket Depth (PPD)
Probing pocket depth (PPD) will be measured in millimeters using a periodontal probe at baseline and 12 months after treatment. The outcome represents the change in PPD between baseline and follow-up.
Baseline to 12 months
Secondary Outcomes (4)
Change in Clinical Attachment Level (CAL)
Baseline to 12 months
Change in Bleeding on Probing (BOP)
Baseline to 12 months
Change in Gingival Index (GI)
Baseline to 12 months
Change in Plaque Index (PI)
Baseline to 12 months
Study Arms (2)
Ozone Group
EXPERIMENTALSites treated with open flap debridement combined with adjunctive ozone therapy.
Control Group
ACTIVE COMPARATORSites treated with open flap debridement alone without adjunctive ozone therapy.
Interventions
Open flap debridement was performed to gain access to root surfaces for removal of subgingival plaque and calculus in sites with periodontal pockets.
Adjunctive ozone therapy was applied to the test sites following open flap debridement using an ozone delivery device according to the manufacturer's instructions.
Eligibility Criteria
You may qualify if:
- Adults aged between 25 and 65 years
- Diagnosed with Stage III periodontitis
- Presence of at least 20 teeth
- Presence of periodontal pockets ≥5 mm in at least two teeth
- Indication for open flap debridement
- Systemically healthy individuals
- No periodontal treatment within the last 6 months
You may not qualify if:
- Pregnant or breastfeeding women
- Presence of systemic diseases that may affect periodontal healing
- Use of antibiotics or anti-inflammatory drugs within the last 6 months
- Smoking or tobacco use
- History of periodontal treatment within the last 6 months
- Patients with poor oral hygiene compliance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Alparslan Dilsizlead
Study Sites (1)
Ataturk University Faculty of Dentistry, Department of Periodontology
Erzurum, Turkey (Türkiye)
Related Publications (1)
Mangal S, Kaushal S, Lal N, Pathak AK, Agarwal B, Shukla S. Comparison of ozone therapy and antimicrobial photodynamic therapy in periodontitis: A randomized clinical trial. J Oral Biol Craniofac Res. 2026 Mar-Apr;16(2):101393. doi: 10.1016/j.jobcr.2025.12.011. Epub 2026 Jan 13.
PMID: 41584216BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 18, 2026
First Posted
April 24, 2026
Study Start
January 1, 2025
Primary Completion
January 25, 2026
Study Completion
February 18, 2026
Last Updated
April 24, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared due to institutional policies and privacy considerations.